×
About 70,933 results

ALLMedicine™ Anemia Center

Research & Reviews  21,154 results

"The Raven Himself Is Hoarse:" Candida dubliniensis fungemia manifesting as an eschar.
https://www.ncbi.nlm.nih.gov/pubmed/35779028
Skinmed Seervai RNH, Wiggins CJ et. al.

Jul 3rd, 2022 - A 65-year-old man with diabetes, end-stage renal disease on hemodialysis, coronary artery disease, and a prosthetic aortic valve. He presented to the emergency department with hypothermia (96.6°F), several weeks of anorexia and chills, and bilater...

A case report: subacute combined degeneration of the spinal cord and pernicious anemia ...
https://doi.org/10.1097/MD.0000000000029226
Medicine Sun Z, Yu X

Jul 2nd, 2022 - Autoimmune gastritis causing both subacute combined degeneration of the spinal cord and pernicious anemia is rare in clinical practice. Here, we report a case of subacute combined degeneration of the spinal cord and pernicious anemia resulting fro...

Double-balloon enteroscopy-assisted polypectomy for a solitary jejunal Peutz-Jeghers po...
https://doi.org/10.1055/a-1866-3758
Endoscopy Onuma K, Sudo G et. al.

Jul 2nd, 2022 - Double-balloon enteroscopy-assisted polypectomy for a solitary jejunal Peutz-Jeghers polyp causing anemia.|2022|Onuma K,Sudo G,Inoue H,Kuriyama T,Takada Y,|

Genetic testing in severe aplastic anemia is required for optimal hematopoietic cell tr...
https://doi.org/10.1182/blood.2022016508
Blood McReynolds LJ, Rafati M et. al.

Jul 2nd, 2022 - Patients with severe aplastic anemia (SAA) can have an unrecognized inherited bone marrow failure syndrome (IBMFS) due to phenotypic heterogeneity. We curated germline genetic variants in 104 IBMFS-associated genes from exome sequencing performed ...

Oligoclonal T-cell expansion in a patient with bone marrow failure after CD19 CAR-T for...
https://doi.org/10.1182/blood.2022017015
Blood Rejeski K, Wu Z et. al.

Jul 2nd, 2022 - The advent of chimeric antigen receptor (CAR) T-cell therapy has revolutionized the treatment landscape of refractory B-cell malignancies. Real-world evidence has highlighted the high incidence of hematological toxicity, including prolonged and pr...

see more →

Guidelines  26 results

Controversies in optimal anemia management: conclusions from a Kidney Disease: Improvin...
https://doi.org/10.1016/j.kint.2021.03.020
Kidney International; Babitt JL, Eisenga MF et. al.

Apr 12th, 2021 - In chronic kidney disease, anemia and disordered iron homeostasis are prevalent and associated with significant adverse consequences. In 2012, Kidney Disease: Improving Global Outcomes (KDIGO) issued an anemia guideline for managing the diagnosis,...

Spotlight: Gastrointestinal Evaluation of Iron Deficiency Anemia.
https://doi.org/10.1053/j.gastro.2020.08.036
Gastroenterology Ko CW, Siddique SM et. al.

Aug 31st, 2020 - Spotlight: Gastrointestinal Evaluation of Iron Deficiency Anemia.|2020|Ko CW,Siddique SM,Patel A,Harris A,Altayar O,|blood,diagnosis,etiology,standards,standards,standards,diagnostic imaging,metabolism,pathology,standards,blood,complications,diagn...

GI Evaluation of Iron Deficiency Anemia: Clinical Decision Support Tool.
https://doi.org/10.1053/j.gastro.2020.08.043
Gastroenterology

Aug 31st, 2020 - GI Evaluation of Iron Deficiency Anemia: Clinical Decision Support Tool.|2020| ,|blood,diagnosis,etiology,standards,methods,standards,standards,diagnostic imaging,metabolism,pathology,standards,blood,complications,diagnosis,pathology,analysis,diag...

AGA Clinical Practice Guidelines on the Gastrointestinal Evaluation of Iron Deficiency ...
https://doi.org/10.1053/j.gastro.2020.06.046
Gastroenterology Ko CW, Siddique SM et. al.

Aug 19th, 2020 - AGA Clinical Practice Guidelines on the Gastrointestinal Evaluation of Iron Deficiency Anemia.|2020|Ko CW,Siddique SM,Patel A,Harris A,Sultan S,|blood,diagnosis,epidemiology,etiology,standards,standards,diagnostic imaging,metabolism,pathology,stan...

Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH...
https://doi.org/10.1200/JCO.18.02142
Journal of Clinical Oncology : Official Journal of the Am... Bohlius J, Bohlke K et. al.

Apr 11th, 2019 - To update the American Society of Clinical Oncology (ASCO)/American Society of Hematology (ASH) recommendations for use of erythropoiesis-stimulating agents (ESAs) in patients with cancer. PubMed and the Cochrane Library were searched for randomiz...

see more →

Drugs  823 results see all →

Clinicaltrials.gov  2,755 results

Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis
https://clinicaltrials.gov/ct2/show/NCT03520647

Jul 1st, 2022 - Severe aplastic anemia (SAA),myelodysplastic syndrome (MDS), and paroxysmal nocturnal hemoglobinuria (PNH) are life-threatening bone marrow disorders. For SAA patients, long term survival can be achieved with immunosuppressive treatment. However, ...

20-Week Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia
https://clinicaltrials.gov/ct2/show/NCT01906489

Jul 1st, 2022 - The purpose of this study is to evaluate the hemoglobin response (efficacy), safety, and tolerability of orally administered AKB-6548 in participants with Chronic Kidney Disease (pre-dialysis) with anemia with dosing for 20 weeks.

Screening for Alpha Thalassemia in Healthy Volunteers
https://clinicaltrials.gov/ct2/show/NCT02692872

Jul 1st, 2022 - Many of the complications of sickle cell disease, such as stroke, kidney damage, skin ulceration,pulmonary hypertension, and cardiac hypertrophy are prevented, delayed or reduced by inheritance of one of more deletions of the alpha globin genes. O...

Retrospective Study of Patients With Severe Aplastic Anemia Who Developed High Risk Clonal Evolution With Chromosome 7 Abnormalities After Immunosuppressive Therapy
https://clinicaltrials.gov/ct2/show/NCT04436367

Jul 1st, 2022 - Severe aplastic anemia (SAA) is a form of bone marrow failure in most cases is the result of a cytotoxic T cell attack on the marrow stem cell. It is effectively treated in most patients with either immunosuppressive treatment (IST) or allogeneic ...

Retrospective Study of Patients With Severe Aplastic Anemia Who Relapsed After Immunosuppressive Therapy
https://clinicaltrials.gov/ct2/show/NCT04436380

Jul 1st, 2022 - Severe aplastic anemia (SAA) is a form of bone marrow failure and in most cases is the result of a cytotoxic T cell attack on the marrow stem cell. It is effectively treated in most patients with either immunosuppressive treatment (IST) or upfront...

see more →

News  3,526 results

Simultaneous Cases of Carfilzomib-Induced Thrombotic Microangiopathy in 2 Patients With Multiple Myeloma
https://www.mdedge.com/fedprac/avaho/article/255829/multiple-myeloma/simultaneous-cases-carfilzomib-induced-thrombotic
Nathaniel J. Myall, MD, Samantha X. Wang, MD et. al.

Jun 28th, 2022 - As a class of drugs, proteasome inhibitors are known to rarely cause drug-induced thrombotic microangiopathy (DITMA). In particular, carfilzomib is a second-generation, irreversible proteasome inhibitor approved for the treatment of relapsed, refr.

Advanced gastric cancer: Ramucirumab-irinotecan combo fails phase 2
https://www.mdedge.com/hematology-oncology/article/255632/gastrointestinal-cancer/advanced-gastric-cancer-ramucirumab

Jun 22nd, 2022 - Key clinical point: Ramucirumab in combination with irinotecan fails to improve the progression-free survival (PFS) rate at 6 months in patients with previously treated advanced gastric cancer. Major finding: The 6-month PFS rate was 26.

Momelotinib Hits the Mark for Deadly Bone Marrow Cancer
https://www.medscape.com/viewarticle/975651

Jun 15th, 2022 - The investigational drug momelotinib has shown benefits in myelofibrosis in a new phase 3 trial, which could now lead to a Food and Drug Administration approval. This drug had previously shown mixed results in a phase 3 trial funded by Gilead, whi...

Momelotinib hits the mark for deadly bone marrow cancer
https://www.mdedge.com/hematology-oncology/article/255402/cml/momelotinib-hits-mark-deadly-bone-marrow-cancer
Heidi Splete

Jun 13th, 2022 - The investigational drug momelotinib has shown benefits in myelofibrosis in a new phase 3 trial, which could now lead to a Food and Drug Administration approval. This drug had previously shown mixed results in a phase 3 trial funded by Gilead, whi.

Should clozapine be discontinued in a patient receiving chemotherapy?
https://www.mdedge.com/psychiatry/article/255053/schizophrenia-other-psychotic-disorders/should-clozapine-be-discontinued
Tyler C. Wright, MD, MPH, Stephanie H. Cho, MD, MS

Jun 1st, 2022 - CASE Schizophrenia, leukemia, and chemotherapy Mr. A, age 30, has schizophrenia but has been stable on clozapine 600 mg/d.

see more →

Patient Education  89 results see all →